¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

°¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø The 10th Catholic VESSEL Update 2018 Symposium & Workshop : 2018-12-07

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
°¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø The 10th Catholic VESSEL Update 2018 Symposium & Workshop : 2018-12-07
±³À°ÀÏÀÚ : 2018-12-07
±³À°Àå¼Ò : ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç  
±³À°ÁÖÁ¦ : The 10th Catholic VESSEL Update 2018 Symposium & Workshop
ÁÖÃÖ±â°ü : °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø
´ã´çÀÚ : ±èÀå¿ë
¿¬¶ôó : 02-2258-2876  
À̸ÞÀÏ : seoulsmsurgery@catholic.ac.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í »çÀüµî·Ïºñ: ¹«·á / ÇöÀåµî·Ïºñ: Àü¹®ÀÇ 50,000¿ø / Àü°øÀÇ, ±ºÀÇ°ü, °£È£»ç µî 20,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 08:00~08:50 Breakfast & Workshop Endoanchor and Onyx  () 
±âŸ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 08:50~09:00 opening address  ¿À¼¼Á¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:00~09:10 AFX II and Ovation  Çѵ¿È£(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:10~09:20 IBD  °øÁØÇõ(¸ÞµðÇ÷º½º ¼¼Á¾º´¿ø) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:20~09:30 Incraft  °í¿µ±¹(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:30~09:40 MFM  °íÀ±¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:40~09:50 Current data of endovascular treatment of juxtarenal AAA (Debranching, ChEVAR, Andoanchor, fenestration)  ¾È»óÇö(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 09:50~10:00 Current data of EVAR  È²È«ÇÊ(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 10:00~10:05 Live from Asahikawa Univ.  Nobuyoshi Azuma(Asahikawa Medical Univ. Japan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 10:05~10:20 Live from Busan Univ. Yangsan Hosp  ÀÌ»ó¼ö(ºÎ»êÀÇ´ë) 
È޽Ġ12-07  10:20~10:30 Coffee Break  () 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 10:30~10:40 ESC new guideline for PAD and its impact in Japanese vascular surgeons  Hiroyoshi Komai(Kansai Medical Univ., Japan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 10:40~10:50 Current role of DCB in PAD Tx 2018  ¹Ú¾çÁø(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 10:50~11:00 Indication of DCS in DCB era 2018  Àü¿ë¼±(ÀÎÇÏÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 11:00~11:10 Life saving and durability with Lifestream stentgraft  À̱¤ÈÆ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 11:10~11:20 Atherectomy as good as expectation?  Á¶ÁøÇö(°æÈñÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 11:20~11:30 My strategies for CLI from Surgeon  Tadahiro Sasajima(Edogawa Hosp., Japan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 11:30~11:40 My strategies for CLI from Interventionist  ³ª½ÂÀ±(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 11:40~12:00 Live from Asahikawa Univ.  Nobuyoshi Azuma(Asahikawa Medical Univ. Japan) 
½Ä»ç 12-07  12:00~13:00 Luncheon: Xarelto PAD study  () 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:00~13:10 Open conversion for continued sac enlargement  ¹Ú¼øö(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:10~13:20 Onyx for endoleak Tx  Á¶°æÀç(Univ. of Michigan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:20~13:30 Endoanchor for Type Ia endoleak  ÃµÈ£Á¾(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:30~13:40 Endovascular Tx for ruptured AAA  ±èÀå¿ë(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:40~13:50 Alternative Imaging during EVAR : CO2 Angio  Á¶°æÀç(Univ. of Michigan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 13:50~14:00 The Updated Guidelines for the Clinical Practice of Contrast Enhanced USG (CEUS)  ÀÌÀ翵(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 14:00~14:10 Prevention and treatment of limb occlusion  Jackie Ho(National Univ. Heart Centre, Singapore)) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 14:10~14:30 Live from Asahikawa (Complex leg bypass)  Nobuyoshi Azuma(Asahikawa Medical Univ. Japan) 
È޽Ġ12-07  14:30~14:40 Coffee Break  () 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 14:40~14:50 complication BTK interven °ü·Ã  À±Ã¢È¯(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 14:50~15:00 ilio-fermoral lession °ü·Ã  °­¿øÀ¯(¼º°¡·Ñ·Îº´¿ø) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 15:00~15:10 Risk factors and management for vascular access-related complication  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 15:10~15:20 EVAR-related complications  ±è¿ëÈÆ(°­¿øÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 15:20~15:40 Technical consideration to prevent TEVAR related complication  ÀÌÇÑö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 15:40~15:50 Endovascular treatment of aortoiliac occlusion  ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 15:50~16:00 Vessel preparation during PTA  ¿øÁ¦È¯(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:00~16:10 IVUS guided PTA  ¿øÈ£¿¬(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:10~16:20 Survived bypass techniques in endovascular era  Taku Kokubo(Edogawa Hosp.. Japan) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:20~16:30 Atheromatous plaque and intimal hyperplasia in PTA  ÃÖÀÍÁØ(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:30~16:40 Anatomies of ankle vascular system  ³²¿ë¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:40~16:50 HBOT for wound healing  ÇÑâ¼·(»ïõÆ÷¼­¿ïº´¿ø) 
±³À°½Ã°£ 12-07 ¼­¿ï¼º¸ðº´¿ø º»°ü ÁöÇÏ 1Ãþ ´ë°­´ç 16:50~17:00 Live from Busan Univ. Yangsan Hosp  ÀÌ»ó¼ö(ºÎ»êÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø The 10th Catholic VESSEL Update 2018 Symposium & Workshop : 2018-12-07""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï¾Æ»êº´¿ø Á¦ 11ȸ ¾Æ»ê±¹Á¦¼ÒÈ­±âº´½ÉÆ÷Áö¾ö(AIDDS) : 2018-12-07
´ÙÀ½±Û 2018³â ´ëÇѼöÇ÷ÇÐȸ/Áúº´°ü¸®º»ºÎ °øµ¿ ½ÉÆ÷Áö¾ö : 2018-12-07
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20589 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GI Cancer 2024 : 2024-06-14 0 57 2024-04-29
20588 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-14 0 56 2024-04-29
20587 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 2ÀÏÂ÷ : 2024-06-14 0 35 2024-04-29
20586 °æºÏ 2024 ´ëÇÑÆó¾ÏÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-14 0 48 2024-04-29
20585 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 1ÀÏÂ÷ : 2024-06-13 0 57 2024-04-29
20584 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-13 0 56 2024-04-29
20583 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-ÃÖ½ÅÇü º¸Ã»±â¿Í ¸ÂÃãÇü º¸Ã»±â ó¹æ¿ä·É : 2024-06-13 0 44 2024-04-29
20582 ¼­¿ï °­³²¼¼ºê¶õ½º ¾È°ú Áö¿ªÀÇ»çÁý´ãȸ(³­Ä¡¼º °¢¸· Áúȯ) : 2024-06-11 0 62 2024-04-29
20581 ¼­¿ï [¿Â¶óÀÎ] Á¦274ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ(Æó±â´É°ú ±â°üÁö°ú¹Î¼º) : 2024-06-11 0 42 2024-04-29
20580 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø [¿Â¶óÀÎ] Á¦ 26 ȸ ¿Ü·¡Â÷¿øÀÇ ¼Ò¾Æû¼Ò³â°ú ÀÓ»ó : 2024-06-09 0 44 2024-04-29
20579 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø ¼øȯ±â³»°ú 16ȸ KOALA Symposium 2024 : 2024-06-09 0 41 2024-04-29
20578 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ (¿Â¶óÀÎ) Á¦3ȸ ¼ö¸é°øµ¿½ÉÆ÷Áö¾ö : 2024-06-09 0 58 2024-04-29
20577 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ 2024 ´ç´¢º´ °³¿øÀÇ ¿¬¼ö°­Á : 2024-06-09 0 66 2024-04-29
20576 ¼­¿ï 2024 ´ëÇѽŰæÁýÁßÄ¡·áÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-08 0 60 2024-04-29
20575 ¼­¿ï 2024 »ó¹Ý±â ´ëÇÑÇ÷¾×ÇÐȸ ´Ù¹ß°ñ¼öÁ¾¿¬±¸È¸ ½ÉÆ÷Áö¾ö(2024 »ó¹Ý±â KMMWP workshop & Àӻ󿬱¸¸ðÀÓ) : 2024-06-08 0 44 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷